Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001493152-24-001134

Director acquired 10,625 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Schoeneck James A Director 2023-12-21 Grant or award +10,625 $1.80 $19,125 27,872 D
Derivatives
Schoeneck James A Director 2023-12-21 Grant or award · Non-Qualified Stock Options (right to buy) +70,249 70,249 D
Loading xslF345X05/ownership.xml…